Amwell to Participate in Upcoming Investor Conferences
- None.
- None.
- On Sept. 6, Ido Schoenberg, MD, Chairman and CEO, and Bob Shepardson, CFO, will participate in one-on-one meetings with investors at the 2023 Wells Fargo Healthcare Conference.
-
On Sept. 12, Dr. Schoenberg and Mr. Shepardson will also participate in an in-person fireside chat at the Morgan Stanley Global Healthcare Conference in
New York and conduct one-on-one meetings with investors. The fireside chat will take place at 2:15 p.m. ET. -
On Sept. 13, Mr. Shepardson will participate in an in-person fireside chat at the Baird 2023 Healthcare Conference in
New York and conduct one-on-one meetings with investors. The fireside chat will take place at 12:15 p.m. ET. - On Sept. 21, Mr. Schoenberg will participate in a panel discussion virtually at the TD Cowen 8th Annual FutureHealth Conference, the time is yet to be scheduled.
Audio webcasts will be available following, at https://investors.amwell.com.
About Amwell
Amwell is a leading digital care delivery enablement platform in
American Well, Amwell, Converge, Conversa, SilverCloud and Carepoints are registered trademarks or trademarks of American Well Corporation in
Forward-Looking Statements
This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in our most recent form 10-K filed with the SEC. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of our website at investors.amwell.com and on the SEC’s website at www.sec.gov.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230829747211/en/
Investor Contact:
Sue Dooley
sue.dooley@amwell.com
415-602-9167
Media Contact:
Angela Vogen
Press@amwell.com
Source: Amwell
